Atara Biotherapeutics Inc

Atara Biotherapeutics Inc

ATRA ·

Atara Biotherapeutics Inc (ATRA) is a Medical pharmaceuticals company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Atara Biotherapeutics Inc in 2026. The next earnings report is expected on October 29, 2026.

Earnings calendar

Next earnings date

29 Oct 2026

In 69 days

EPS estimate

-0.29

Revenue estimate

750.0K

Past earnings

12 Aug 2026
EPS actual
-0.32 (0.0%)
estimate -0.32
Revenue actual
550.0K (0.0%)
estimate 550.0K
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
12 May 2026
EPS actual
-0.29 (+12.0%)
estimate -0.33
Revenue actual
516.0K (-82.2%)
estimate 2.9M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
16 Mar 2026
EPS actual
-0.25 (-42.1%)
estimate -0.18
Revenue actual
1.6M (-51.2%)
estimate 3.4M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
12 Nov 2025
EPS actual
-0.32 (+52.0%)
estimate -0.67
Revenue actual
3.5M (-7.5%)
estimate 3.7M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Atara Biotherapeutics met consensus estimates in its latest earnings report, with EPS of -$0.315 matching forecasts and revenue of $550 thousand also in line with estimates, a 0.0% surprise. In the prior quarter EPS came in ahead of expectations while revenue fell short of estimates.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

Sector
Healthcare
Industry
Medical pharmaceuticals
Country
United States
Exchange
Nasdaq
CEO
Anhco Nguyen
Employees
14
IPO date
29 Jan 2018
ISIN
US0465132068
Website
atarabio.com

Frequently asked questions

When does Atara Biotherapeutics Inc (ATRA) next report earnings?

Atara Biotherapeutics Inc (ATRA) is scheduled to report earnings on October 29, 2026.

What was Atara Biotherapeutics Inc's most recent earnings date?

Atara Biotherapeutics Inc (ATRA) last reported earnings on August 12, 2026.

Where is Atara Biotherapeutics Inc stock listed?

Atara Biotherapeutics Inc (ATRA) is listed on Nasdaq.